Suppr超能文献

西咪替丁与尼可香豆素在人体中的相互作用:立体化学考量

Cimetidine-nicoumalone interaction in man: stereochemical considerations.

作者信息

Gill T S, Hopkins K J, Bottomley J, Gupta S K, Rowland M

机构信息

Department of Pharmacy, University of Manchester.

出版信息

Br J Clin Pharmacol. 1989 Apr;27(4):469-74. doi: 10.1111/j.1365-2125.1989.tb05395.x.

Abstract
  1. The cimetidine-nicoumalone interaction was studied in five subjects who received a single 10 mg oral dose of racemic nicoumalone alone and 3 days into an oral regimen of cimetidine of 200 mg three times daily and 400 mg at night. 2. The concentrations of R(+)- and S(-)-nicoumalone in plasma were measured using a stereospecific h.p.l.c assay; augmentation of prothrombin time was used as a measure of response. 3. Cimetidine increased the rate (but not extent) of absorption of both R(+)- and S(-)-nicoumalone, and reduced the clearance of R(+)-nicoumalone but not that of the S(-)-enantiomer. 4. Cimetidine increased the anticoagulant response produced by nicoumalone in some but not all subjects, despite a consistent effect on the pharmacokinetics of the oral anti-coagulant. 5. Cimetidine appears to produce its effect by stereoselectively inhibiting the elimination of R(+)-nicoumalone.
摘要
  1. 在5名受试者中研究了西咪替丁与尼可香豆素的相互作用。这些受试者单独口服10mg消旋尼可香豆素单次剂量,且在每日三次口服200mg西咪替丁及晚上口服400mg的治疗方案3天后进行研究。2. 使用立体特异性高效液相色谱法测定血浆中R(+)-和S(-)-尼可香豆素的浓度;凝血酶原时间延长用作反应指标。3. 西咪替丁增加了R(+)-和S(-)-尼可香豆素的吸收速率(但不是程度),并降低了R(+)-尼可香豆素的清除率,但未降低S(-)-对映体的清除率。4. 尽管西咪替丁对口服抗凝药的药代动力学有一致影响,但在部分而非所有受试者中,它增加了尼可香豆素产生的抗凝反应。5. 西咪替丁似乎通过立体选择性抑制R(+)-尼可香豆素的消除而产生作用。

相似文献

1
Cimetidine-nicoumalone interaction in man: stereochemical considerations.
Br J Clin Pharmacol. 1989 Apr;27(4):469-74. doi: 10.1111/j.1365-2125.1989.tb05395.x.
2
Lack of effect of ponsinomycin on the pharmacokinetics of nicoumalone enantiomers.
Br J Clin Pharmacol. 1990 Oct;30(4):616-20. doi: 10.1111/j.1365-2125.1990.tb03822.x.
3
Stereospecific assay of nicoumalone: application to pharmacokinetic studies in man.
Br J Clin Pharmacol. 1988 May;25(5):591-8. doi: 10.1111/j.1365-2125.1988.tb03350.x.
4
Cimetidine: interaction with oral anticoagulants in man.
Lancet. 1979 Aug 18;2(8138):317-9. doi: 10.1016/s0140-6736(79)90340-4.
6
The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.
Eur J Clin Pharmacol. 1999 Jul;55(5):399-404. doi: 10.1007/s002280050647.
7
No effect of short-term omeprazole intake on acenocoumarol pharmacokinetics and pharmacodynamics.
Br J Clin Pharmacol. 1997 Oct;44(4):399-401. doi: 10.1046/j.1365-2125.1997.00600.x.
8
Detection of drug interactions with single dose acenocoumarol: new screening method?
Int J Clin Pharmacol Ther Toxicol. 1990 Aug;28(8):355-60.

引用本文的文献

1
Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.
Clin Pharmacokinet. 2005;44(12):1227-46. doi: 10.2165/00003088-200544120-00003.
2
A placebo-controlled pharmacodynamic and pharmacokinetic interaction study between tamsulosin and acenocoumarol.
Br J Clin Pharmacol. 2003 Mar;55(3):314-6. doi: 10.1046/j.1365-2125.2003.01793.x.
4
Lack of effect of ponsinomycin on the pharmacokinetics of nicoumalone enantiomers.
Br J Clin Pharmacol. 1990 Oct;30(4):616-20. doi: 10.1111/j.1365-2125.1990.tb03822.x.

本文引用的文献

2
Pharmacokinetics of the enantiomers of acenocoumarol in man.
Br J Clin Pharmacol. 1981 Nov;12(5):621-9. doi: 10.1111/j.1365-2125.1981.tb01280.x.
3
Pharmacokinetics of cimetidine after single doses and during continuous treatment.
Clin Pharmacokinet. 1981 Jul-Aug;6(4):306-15. doi: 10.2165/00003088-198106040-00005.
6
Cimetidine as an inhibitor of drug metabolism: therapeutic implications and review of the literature.
Drug Intell Clin Pharm. 1982 May;16(5):380-6. doi: 10.1177/106002808201600504.
7
Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
J Clin Invest. 1974 Jun;53(6):1607-17. doi: 10.1172/JCI107711.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验